Articles On Bioxyne (ASX:BXN)
Title | Source | Codes | Date |
---|---|---|---|
Crucible: Dr Boreham’s A-To-Z of 2024 biotech
From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose... |
Stockhead | BXN | 6 days ago |
Closing Bell: ASX slides from record high; expert says December pullback may encourage buying
ASX loses momentum after near-record high Tech stocks lead, but CSL falls; retail sales rise 0.6% in October Northern Star to buy De Grey for $5 billion The ASX has lost some of its early momentum today, pulling back from a record high... |
Stockhead | BXN | 2 weeks ago |
Closing Bell: ASX up on broad rally; but City Chic tumbles heavily after trading update
ASX rises on rally across the board Israel and Hezbollah agree to 60-day ceasefire City Chic tumbles after downbeat update The Aussie share market enjoyed a solid ride on Wednesday, driven by a broad rally as optimism from Wall Street’s... |
Stockhead | BXN | 3 weeks ago |
Health Check: Chinese consumer market is a thing of beauty, says EZZ Life Sciences
Chinese shoppers have not lost their appetite for EZZ’s health and beauty products Ho-Ho-Ho (Chi Minh)! Viet deal is an early Xmas prez for Truscreen holders Patrys says it will focus on its Plan B drug candidate China is a tough consum... |
Stockhead | BXN | 4 weeks ago |
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Robert F Kennedy Junior’s appointment as US health czar means an unpredictable time for ASX healthcare companies operating in the US The likely consequences are not all bad, with many stocks poised to benefit from tax cuts and a more effic... |
Stockhead | BXN | 1 month ago |
Top 10 at 11: Drug breakthrough, fresh drilling and a gas sale are today’s morning news
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | BXN | 2 months ago |
Closing Bell: Iron ore giants help ASX to another record; RBA rate cut far-off as job market stays tight
ASX200 hits record high driven by US Fed interest rate cut Mining stocks surge as iron ore prices rebound ALS shares drop 10pc, Monadelphous rises on new contracts The ASX200 hit yet another record high today, boosted by the first inte... |
Stockhead | BXN | 3 months ago |
Closing Bell: ASX lifts as CBA, Mac Bank hit record highs; Aruma Resources doubles
ASX closes higher as CBA and Macquarie touch records Lotus Resources finds significant uranium; gold stocks await US CPI data UBS favours ASX banks over miners The ASX bounced back by 0.4% on Tuesday after yesterday’s slump, with the... |
Stockhead | BXN | 3 months ago |
ASX August Winners: The 50 best stocks in a volatile month for markets
S&P/ASX 200 recovers from heavy volatility early in the month to finish up 0.47% in August S&P Dow Jones Indices said mid-caps led the gains putting them ahead of large and small caps YTD Larvotto Resources rose on the back of Chin... |
Stockhead | BXN | 3 months ago |
Closing Bell: ASX slides as Qantas’ profit takes big dip; MC Mining triples on Chinese coal deal
The ASX lagged on Thursday after Nvidia’s disappointing Q3 guidance Mineral Resources fell 8pc off a major profit drop Qantas saw a 28pc drop in profit but saw modest share price gains The ASX was sluggish on Thursday, down 0.33%, follo... |
Stockhead | BXN | 3 months ago |
Long Shortz with Bioxyne: It’s all go for gummies made yummy with cannabis in Aussie first
Stockhead’s Fraser Palamara sits down with Bioxyne’s (ASX:BXN) founder and CEO Sam Watson to get the short end of the long story on the company’s latest news. Bioxyne, the parent company of Breath Life Sciences, has manufactured and deliver... |
Stockhead | BXN | 3 months ago |
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators
ASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price rebound, energy stocks fell The ASX 200 ended its 10-day winning streak, dipping by 0.04% after a weak session on Wall Street overnight.... |
Stockhead | BXN | 3 months ago |
Top 10 at 11: Spanner thrown in green machine as ASX sectors trend down
Good morning, and welcome to Stockhead’s Top 10 at somewher enear 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | BXN | 4 months ago |
Closing Bell: ASX made it 10 on the trot, adding 0.21pc thanks to big movers in tech and mining
ASX 200 banked its 10th straight win, climbing 0.21pc to 8,027.00 points InfoTech and Resources were the stand-out sectors today Who won among the small caps? You’ll need to read on to find out The ASX has hit 10 winners in a row, which... |
Stockhead | BXN | 4 months ago |
THC gummies are getting popular, here are 3 ASX cannabis companies offering the product
THC gummies are becoming popular for their convenience and effects Bioxyne has produced Australia’s first GMP-certified cannabis gummies Bioxyne is expanding production to meet rising demand Functional foods are growing in popularity as... |
Stockhead | BXN | 4 months ago |
Top 10 at 11: Lithium takeover and antimony acrimony are making today’s news
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | BXN | 4 months ago |
Closing Bell: ASX resets on mild mannered Monday gains
ASX rises circa 0.5pc Consumer stocks in focus this week SGQ and PHX lead small caps Aussie stocks have closed higher on Monday as IT and retail stocks added strength to sentiment. The S&P/ASX200 closed higher, gaining 36.00 points... |
Stockhead | BXN | 4 months ago |
Top 10 at 11: Confidence and calm brighten ASX on Monday morning
Good morning, and welcome to Stockhead’s Top 10 at around 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading... |
Stockhead | BXN | 4 months ago |
Closing Bell: Markets still bumpy as ASX drops again; Qantas admits board made mistakes
The ASX dropped, dragged down by Real Estate and Mining stocks Qantas cuts former CEO’s compensation by $9.3m Fears of a US recession are growing, with the Sahm Rule signalling potential trouble A selloff in Real Estate and Mining stock... |
Stockhead | BXN | 4 months ago |
Top 10 at 11: Inifini tops the morning list after finding all of the uranium
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish – with the best (and sometimes worst) performing ASX stocks in morning trade. We use live data to help frame the ASX trading day through the biggest movers in percenta... |
Stockhead | BXN | 5 months ago |
Top 10 at 11-ish: A Big Red peggie gets even bigger and QLD gets a high-grade gold-copper hit
Good morning, and welcome to Stockhead’s Top 10 at shortly-after-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the t... |
Stockhead | BXN | 5 months ago |
Closing Bell: Benchmark trims gains ahead of US inflation tonight and month end portfolio positioning
ASX 200 hit by afternoon profit taking, closing at +0.1pc for the day. 9 of 11 ASX sectors were higher, so… two of them weren’t. Small cap gains led by East33, and the world is their oyster. Local markets trimmed most of the early mor... |
Stockhead | BXN | 5 months ago |
Top 10 at 10: This lithium brines stock is pumping in early trade Tuesday
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | BXN | 6 months ago |
Closing Bell: Most ASX sectors flashing red today, as RAU makes solid market debut
ASX200 dropped on Friday, extending its weekly loss despite Wall Street’s highs Telix Pharma halted US IPO; Tabcorp jumps 10pc on NSW tax reform Germany works to soften EU tariffs on Chinese electric cars The ASX200 dropped by -0.3% on... |
Stockhead | BXN | 6 months ago |
Patient investors may well be rewarded as the milk industry navigates a ‘perfect storm’
Aussie dairy industry finds itself in a ‘perfect storm’ Dairy processors such as Beston are proactively embracing innovations to survive Despite the hurdles, investors with patience might find promising prospects ahead The current crisi... |
Stockhead | BXN | 6 months ago |
Closing Bell: ASX takes a 1pc hit as inflation spooks; IMF bullish on China
Aussie stocks fell 1pc on rising inflation ASX sectors mostly down; IAG hit by class action lawsuit Asian markets dropped; IMF ups China’s growth forecast to 5pc Aussie stocks fell by 1% on Wednesday, hitting their lowest point in three... |
Stockhead | BXN | 6 months ago |
Bioxyne highlights risks of unregulated psychedelic use
Bioxyne emphasises importance of stringent regulatory frameworks for safe use of psychedelics and cannabis Company highlights risks of incorrect dosages, impure substances, and lack of medical supervision Bioxyne subsidiary awarded Austral... |
Stockhead | BXN | 6 months ago |
So mushroom for growth: Bioxyne subsidiary inks psilocybin deal with Swiss pharma company
Subsidiary of Bioxyne enters deal with Cy Biopharma AG of Switzerland Companies will develop psilocybin products to treat depression and pain in Australia and New Zealand markets Deal enables manufacture and supply of Australian, New Zea... |
Stockhead | BXN | 7 months ago |
Closing Bell: Oil weighs on flat ASX; Errawarra jumps 65pc on scent of fresh lithium
ASX flat on Monday, ahead of Federal Budget Tuesday night Oil weakness drags Energy sector lower Chinese shares slump on new US tariffs After advancing 1.5% last week, the ASX200 fell flat on Monday – greenish by 0.01% – dragged down m... |
Stockhead | BXN | 7 months ago |
Closing Bell: Iceni Gold skyrockets 300pc on ‘spectacular discovery’; Perpetual to split up
ASX closed flattish on Wednesday after toying with a higher open Perpetual’s shake-up saw shares drop 6pc as KKR snags business parts Iceni Gold jumped over 300pc on discoveries at its Christmas Gift site After opening higher, the ASX c... |
Stockhead | BXN | 7 months ago |
Top 10 at 11: Who is getting decent results in this morning?
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | BXN | 7 months ago |
ASX April Winners: The best 50 stocks as inflation and Middle East tension cloud markets
S&P/ASX 200 fell 2.94% in April as all Australian equity indexes fell except Emerging Companies Utilities and Materials the only ASX sectors in positive territory for April, up 4.77% and 0.61% respectively Rincon Resources tops the wi... |
Stockhead | BXN | 7 months ago |
Closing Bell: Lithium stocks flash green; suitor lobs bid for Sihayo Gold
The ASX inched higher on Tuesday ahead of the Fed’s rates call Lithium stocks flashed green today Amazon, CocaCola, Eli Lilly to report earnings later tonight The ASX200 edged cautiously higher by +0.35% on Tuesday on the back of a Wall... |
Stockhead | BXN | 7 months ago |
Closing Bell: ASX clipped -1.3pc on broad selloff; BHP makes a $60bn play for Anglo American
The ASX slumped by over -1pc, as jitters about delayed rate cuts rattled markets Miner BHP confirmed $60 billion bid for competitor Anglo American Gold stocks climbed, but all 11 sectors closed in the red The ASX 200 declined sharply b... |
Stockhead | BXN | 7 months ago |
Top 10 at 10: Billionaire Richard White just doubled down on Vinyl, gold major flies
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | BXN | 7 months ago |
Closing Bell: ASX up as unemployment rate ticks higher; BHP, Nimy Resources gain
The ASX close higher as unemployment rate came in lower than expected Miners rally, led by BHP as the giant released its Q3 report Nimy Resources up 50pc after reporting promising intercepts The ASX added 0.5% on Thursday as the unemp... |
Stockhead | BXN | 8 months ago |
Bioxyne receives commitments to raise funds to further product development
Australian life sciences, pharmaceutical and consumer health products company Bioxyne (ASX:BXN) has received firm commitments to raise $1.45 million. |
BiotechDispatch | BXN | 8 months ago |
Closing Bell: ASX gains as lithium, iron ore miners dazzle; copper and gold stocks extend rally
The ASX200 closed +0.5% higher on Tuesday on the back of a big lift in the Mining sector. Lithium stocks led, with IGO (ASX:IGO) and Pilbara (ASX:PLS) gaining around 3%. Iron ore miners rallied after the Nymex CFR China, 62% Fe price swu... |
Stockhead | BXN | 8 months ago |
Kula share price gets warmer with new gold sting
This week’s Bulls N’ Bears top ASX runner is … Kula Gold. Its share price rose 100 per cent to join fellow movers and shakers Tali Digital, Bioxyne and Venture Minerals. |
The West | BXN | 10 months ago |
Bioxyne secures Australia's first GMP license for Psilocybin and MDMA
Bioxyne (ASX:BXN) has announced that its subsidiary, Breathe Life Sciences, has been awarded a Good Manufacturing Practice license for the production of medical cannabis. |
BiotechDispatch | BXN | 10 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | BXN | 1 year ago |
Bioxyne subsidiary imports $3.2million of premium quality cannabis flower into Australia
Bioxyne’s subsidiary imports 200kg of premium high THC cannabis flower across three strains into Australia Company is first company to import cannabis into Australia from the UK, the world’s biggest cannabis producer for medical and scient... |
Stockhead | BXN | 1 year ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | BXN | 1 year ago |
Closing Bell: Local markets end 0.4pc higher led by big banks and a few small biotechs
Benchmark index finishes Friday ahead +0.4% Sectors led by Financials Small caps dominated by Dimerix The ASX200 is up +0.4% at the end of Friday trade, making the week a 1% loss, which we’ll take at this stage. US equities ticked l... |
Stockhead | BXN | 1 year ago |
Closing Bell: Small cap biopharma injects a little excitement as ASX finally finds a Thursday butt to kick
Benchmark index finds some rare greenage, up 0.5% Property and IT Sectors lead broad-based gains, XEC Emerging Co’s index now down 14% from July highs Fascinating small caps action: led by Dimerix, Bluglass and Experience Co. The ASX2... |
Stockhead | BXN | 1 year ago |
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet
Benchmark index falls on Monday, closing out the day down 0.21% Utilities and Materials sectors edge higher, but Health Care anchors the benchmark into the red Small caps led by Galileo Mining, Infinity and last week’s rockstar Biotron... |
Stockhead | BXN | 1 year ago |
Top 10 at 11: Not a lot of movement, but there’s not a whole lot of news.
Stockhead’s Top 10 at shortly-before-11-ish, produced through a blistering “I spent all weekend in the sun watching 1,500 kids play soccer” headache, and quietly praying for death. Top 10 highlights the best (and sometimes worst) performing... |
Stockhead | BXN | 1 year ago |
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks Be... |
Stockhead | BXN | 1 year ago |
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Morgans says companies on the ASX are propelling our appetite product for health and wellness products Bioxyne says Covid has shown our susceptibility to disease, but also how resilient and strong we are in fighting it Anagenics says it’s... |
Stockhead | BXN | 1 year ago |
Riding the wave of wellness: The growing non-alcoholic, herbal, and alternative beverage market
In recent years, consumer preferences have undergone a notable shift towards alternative beverages that offer calming effects without the downsides associated with alcohol consumption. This trend presents a lucrative opportunity for inve... |
themarketherald.com.au | BXN | 1 year ago |